What is Eye Site?
Established in 1971, Eye Site has evolved into a cornerstone of the regional healthcare landscape, offering a comprehensive suite of services ranging from preventative eye care to complex surgical interventions. The practice distinguishes itself through a multidisciplinary team of fellowship-trained ophthalmologists and optometrists who utilize advanced laser-assisted technology to treat conditions such as cataracts, glaucoma, and retinal diseases. Beyond clinical diagnostics and surgical procedures, the company maintains a strong retail presence, providing high-quality optical solutions and cosmetic treatments. This integrated model allows Eye Site to maintain a high standard of patient-centric care while navigating the complexities of the modern medical services market.
How much funding has Eye Site raised?
Eye Site has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Eye Site
PPP
Public-Private Partnership
What's next for Eye Site?
With the infusion of this late-stage capital, Eye Site is well-positioned to accelerate its growth strategy and deepen its penetration in the Florida healthcare market. The organization is expected to prioritize the integration of next-generation diagnostic tools and the expansion of its surgical facilities to meet the rising demand for specialized eye care. Furthermore, the firm will likely focus on optimizing its patient management systems to improve clinical outcomes and operational efficiency. As the company continues to scale, this financial backing provides the necessary runway to explore new service lines and potentially expand its geographic reach, ensuring that Eye Site remains at the forefront of ophthalmic innovation and patient service excellence.
See full Eye Site company page
